Clinical trial
Interest in Programming Caesarean Section at 38 Weeks of Pregnancy With Antenatal Betamethasone to Prevent Neonatal Respiratory Distress and to Avoid Emergency Caesarean Section Before Planned Date.
NCT00446953 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest in Programming Caesarean Section at 38 Weeks of Pregnancy With Antenatal Betamethasone to Prevent Neonatal Respiratory Distress and to Avoid Emergency Caesarean Section Before Planned Date.
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- November 30, 2013
- Enrollment
- 200 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
neonatal distress